{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:22Z","timestamp":1786123342758,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Sugammadex binds progesterone with high affinity and may interfere with hormonal contraceptive effectiveness. The clinical, economical, and ethical implications of unintended pregnancy should prompt anesthesiologists to actively consider and manage this pharmacologic interaction. We surveyed anesthesiology providers at our institution about knowledge of this potential adverse drug interaction, how they manage it clinically, and the extent to which they involve patients in shared decision-making regarding choice of neuromuscular blocker antagonist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>A survey instrument was distributed to anesthesiology providers at a large, tertiary-care medical center. The survey explored prior experience using neostigmine and sugammadex, knowledge about potential sugammadex interference with hormonal contraception, pre-\/postoperative counseling practices, clinical management, and shared decision-making regarding potential use of neostigmine in lieu of sugammadex to avoid this drug-drug interaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 259 surveys distributed, 155 were fully completed, and 10 were partially completed. Overall response rate was 60% (residents 85%, student nurse anesthetists 53%, certified registered nurse anesthetists 58%, attendings 48%). All but 1 respondent recognized the potential for sugammadex interference with oral hormonal contraception. Far fewer accurately identified potential interference with hormonal intrauterine devices (44%) and hormonal contraceptive implants (55%). The manufacturer\u2019s recommended 7-day duration of alternative contraception was correctly identified by 72% of respondents; others (22%) reported longer durations (range 10\u201330 days). Most (78% overall) agreed\/strongly agreed that potential interference with contraceptive effectiveness should be discussed with patients preoperatively. Despite the majority (86% overall) that endorsed shared decision-making and inviting patient input regarding choice between sugammadex and neostigmine, many respondents reported \u201crarely\/never\u201d having discussed this drug interaction with patients in actual clinical practice, either preoperatively (67%) or postoperatively (80%). Furthermore, most respondents (79%) reported \u201crarely\/never\u201d administering neostigmine to intentionally avoid this drug interaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Two years after designating sugammadex as antagonist of choice, physician and nurse anesthesia providers reported seldom inquiring about contraceptive use among women of childbearing potential and rarely discussing potential risk of contraceptive failure from sugammadex exposure. Most lack accurate knowledge of sugammadex interference with hormonal intrauterine and subcutaneous contraceptive devices. Although most endorse preoperative counseling and support patient autonomy or shared decision-making regarding choice of reversal agent, the same respondents report rarely, if ever, actualizing these positions in clinical practice. These conflicting findings highlight the need for education regarding residual neuromuscular block versus adverse drug interactions, collaboration among providers involved in patient counseling, and intentional mindfulness of reproductive justice when caring for women of childbearing potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005465","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T17:00:08Z","timestamp":1615222808000},"page":"958-966","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Unanticipated Consequences of Switching to Sugammadex: Anesthesia Provider Survey on the Hormone Contraceptive Drug Interaction"],"prefix":"10.1213","volume":"133","author":[{"given":"Robyn L.","family":"Dwan","sequence":"first","affiliation":[{"name":"From the Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britany L.","family":"Raymond","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Richardson","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1213\/ANE.0000000000004305","article-title":"Sugammadex administration in pregnant women and in women of reproductive potential: a narrative review.","volume":"130","author":"Richardson","year":"2020","journal-title":"Anesth Analg"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1213\/ANE.0000000000003608","article-title":"Informed consent for sugammadex and oral contraceptives: through the looking glass.","volume":"127","author":"Webber","year":"2018","journal-title":"Anesth Analg"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00540-019-02725-2","article-title":"Pre-and post-operative counseling for women on hormonal contraceptives receiving sugammadex at an academic hospital.","volume":"34","author":"Lazorwitz","year":"2020","journal-title":"J Anesth"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1213\/ANE.0000000000002856","article-title":"Approaches to patient counseling regarding effectiveness of oral contraceptives.","volume":"126","author":"DeAndrade","year":"2018","journal-title":"Anesth Analg"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/anae.14176","article-title":"Sugammadex advice for women of childbearing age.","volume":"73","author":"Williams","year":"2018","journal-title":"Anaesthesia"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/anae.13356","article-title":"Sugammadex - time of onset: nine months.","volume":"71","author":"Dalton","year":"2016","journal-title":"Anaesthesia"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/13625187.2020.1815008","article-title":"Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route.","volume":"25","author":"Hofmann","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.contraception.2017.10.003","article-title":"Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014.","volume":"97","author":"Kavanaugh","year":"2018","journal-title":"Contraception"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jopan.2018.10.003","article-title":"Performance-improvement project: increasing nursing knowledge of the impact of sugammadex in female patients taking steroidal contraceptives.","volume":"34","author":"O\u2019Driscoll","year":"2019","journal-title":"J Perianesth Nurs"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2004.03.009","article-title":"Contraceptive failure in the United States.","volume":"70","author":"Trussell","year":"2004","journal-title":"Contraception"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1111\/j.1553-2712.2012.01425.x","article-title":"Patient understanding of emergency department discharge instructions: where are knowledge deficits greatest?","volume":"19","author":"Engel","year":"2012","journal-title":"Acad Emerg Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"S866","DOI":"10.1016\/j.ajog.2019.11.1269","article-title":"From uptake to access: a decade of learning from the ACOG LARC program.","volume":"222","author":"Horvath","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20250502","first-page":"703","article-title":"Values-based practice in primary care: easing the tensions between individual values, ethical principles and best evidence.","volume":"56","author":"Petrova","year":"2006","journal-title":"Br J Gen Pract"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12630-012-9696-6","article-title":"Influences observed on incidence and reporting of medication errors in anesthesia.","volume":"59","author":"Cooper","year":"2012","journal-title":"Can J Anaesth"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MOP.0b013e3283329937","article-title":"The unintended consequences of quality improvement.","volume":"21","author":"Bardach","year":"2009","journal-title":"Curr Opin Pediatr"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:16Z","timestamp":1786112776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005465","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,8]]}}}